The portfolio of our preclinical Neuropharmacology group covers various validated transgenic and non-transgenic in vivo and in vitro models for neurodegeneration such as AD, PD, for orphan diseases including HD and ALS , for lipid storage disease and dyslipidemia, and for diseases like psychosis, anxiety, schizophrenia, or autism. read more
QPS Austria Interviews Employee Reviews
All
Positive
Constructive
What did you like most about the interview process?
There aren't any Interviews reviews of QPS Austria yet.
Be the first to contribute a review.
What would you improve about your company's interview process?
There aren't any Interviews reviews of QPS Austria yet.
Be the first to contribute a review.
×